We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+30.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$43.1B
AUM Growth
+$3.9B
Cap. Flow
+$196M
Cap. Flow %
0.46%
Top 10 Hldgs %
17.24%
Holding
3,508
New
269
Increased
1,735
Reduced
1,181
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Healthcare 9.13%
3 Financials 8.63%
4 Industrials 6.92%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUTR
2601
DELISTED
Cutera, Inc.
CUTR
$342K ﹤0.01%
+16,502
New +$326K
MUX icon
2602
McEwen Inc
MUX
$1.18B
$341K ﹤0.01%
11,210
+326
+3% +$11.8K
NWE icon
2603
NorthWestern Energy
NWE
$4.43B
$341K ﹤0.01%
5,818
-3,035
-34% -$174K
CTR
2604
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$341K ﹤0.01%
5,006
-337
-6% -$22.6K
DNI
2605
DELISTED
Dividend and Income Fund
DNI
$341K ﹤0.01%
+28,311
New +$344K
HLT icon
2606
Hilton Worldwide
HLT
$71.5B
$340K ﹤0.01%
5,811
-3,412
-37% -$198K
ANF icon
2607
Abercrombie & Fitch
ANF
$5B
$339K ﹤0.01%
+28,377
New +$338K
GSBD icon
2608
Goldman Sachs BDC
GSBD
$1.1B
$339K ﹤0.01%
13,738
-19,530
-59% -$475K
KEM
2609
DELISTED
KEMET Corporation
KEM
$339K ﹤0.01%
28,291
+11,419
+68% +$103K
PIPR icon
2610
Piper Sandler
PIPR
$5.29B
$338K ﹤0.01%
21,152
WMGI
2611
DELISTED
Wright Medical Group Inc
WMGI
$338K ﹤0.01%
10,875
-527
-5% -$14.3K
XHE icon
2612
State Street SPDR S&P Health Care Equipment ETF
XHE
$165M
$337K ﹤0.01%
5,991
+1,210
+25% +$64.7K
YRD
2613
Yiren Digital
YRD
$110M
$337K ﹤0.01%
13,440
+2,445
+22% +$58.5K
ETFC
2614
DELISTED
E*Trade Financial Corporation
ETFC
$333K ﹤0.01%
+9,542
New +$342K
AAAP
2615
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$333K ﹤0.01%
+8,359
New +$288K
CEO
2616
DELISTED
CNOOC Limited
CEO
$333K ﹤0.01%
2,776
+93
+3% +$11.4K
EMBJ
2617
Embraer S.A. ADS
EMBJ
$13B
$332K ﹤0.01%
15,035
+2,300
+18% +$52.4K
OSPN icon
2618
OneSpan
OSPN
$618M
$332K ﹤0.01%
24,569
+5,712
+30% +$80.2K
EFII
2619
DELISTED
Electronics for Imaging
EFII
$332K ﹤0.01%
6,807
+349
+5% +$16.1K
AKBA icon
2620
Akebia Therapeutics
AKBA
$252M
$331K ﹤0.01%
35,998
+2,184
+6% +$21.3K
NAN icon
2621
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$331K ﹤0.01%
24,404
+3,600
+17% +$48.9K
CSTM icon
2622
Constellium
CSTM
$3.99B
$330K ﹤0.01%
50,796
-2
-0% -$14
MLPX icon
2623
Global X MLP & Energy Infrastructure ETF
MLPX
$3.5B
$330K ﹤0.01%
7,455
-13,029
-64% -$579K
BKD icon
2624
Brookdale Senior Living
BKD
$3.4B
$329K ﹤0.01%
24,493
+4,788
+24% +$67.6K
ILCG icon
2625
iShares Morningstar Growth ETF
ILCG
$3.28B
$329K ﹤0.01%
12,490
-1,285
-9% -$33K

Similar funds

Raymond James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Raymond James & Associates held 3,508 positions worth $43.1B, up 10% from $39.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James & Associates's Q1 2017 filing shows 269 new, 1,735 increased, 1,181 reduced and 217 closed positions. Its largest new stake was iShares Global REIT ETF: 2,916,742 shares worth $73.9M. The largest sale was TotalEnergies, an estimated $1.85B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2017 buy was iShares Global REIT ETF: 2,916,742 shares worth $73.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $997M increase.
  • Raymond James & Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $1.85B.
  • Raymond James & Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $23.6M.
  • Raymond James & Associates's ten largest holdings make up 17% of its $43.1B portfolio in Q1 2017.
  • Raymond James & Associates opened 269 new positions and closed 217 in Q1 2017.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $43.1B.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.